# Effects of fatty acids and cholesterol on functions and behavior of bone marrow mesenchymal stem cells

**Authors:** Blanca Gonzalez-Garcia, Miriam Plaza, Maria Fresco, Cristina Aparicio, Rocio Abia, Francisco J.G. Muriana, Sara M. Jaramillo-Carmona

PMC · DOI: 10.1016/j.isci.2026.114813 · iScience · 2026-02-10

## TL;DR

This review explores how fatty acids and cholesterol affect the function and behavior of bone marrow mesenchymal stem cells, which are important for bone health and regenerative therapy.

## Contribution

The paper provides a comprehensive review of how major health-related lipids regulate the stemness and function of bone marrow mesenchymal stem cells.

## Key findings

- Fatty acids and cholesterol influence the stemness and rejuvenation of BM-MSCs.
- BM acts as both a receptor and producer of lipids, impacting cell behavior.
- Endocannabinoids and short-chain fatty acids play roles in regulating BM-MSC commitment.

## Abstract

Bone marrow (BM) mesenchymal stem cells (BM-MSCs) have a crucial role in BM homeostasis and regenerative therapy. While lipids are known to be fundamental components of metabolism, their precise role in modulating the function and behavior of BM-MSCs remains unclear. In this review, we present a comprehensive update on the biology of BM-MSCs in response to fatty acids and cholesterol, which are the major health-related lipids. We discuss the importance of BM as a receptor and producer of lipids and summarize the mechanistic insights by which cholesterol and fatty acids, including endocannabinoids and short-chain fatty acids, regulate BM-MSC stemness, rejuvenation, and commitment. Understanding the complex and interdependent role of lipids on BM-MSCs is critical for proper BM and bone homeostasis. Future research should focus on the development of metabolic strategies to optimize health of the BM and its cells and to refine treatments for BM-related diseases or tissue regeneration.

Stem cells research

## Linked entities

- **Chemicals:** fatty acids (PubChem CID 264), cholesterol (PubChem CID 5997)

## Full-text entities

- **Genes:** CD34 (CD34 molecule) [NCBI Gene 947], NAAA (N-acylethanolamine acid amidase) [NCBI Gene 27163] {aka ASAHL, PLT}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, CSPG4 (chondroitin sulfate proteoglycan 4) [NCBI Gene 1464] {aka CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16}, CNR2 (cannabinoid receptor 2) [NCBI Gene 1269] {aka CB-2, CB2, CX5}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469] {aka HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, TAC1 (tachykinin precursor 1) [NCBI Gene 6863] {aka Hs.2563, NK2, NKNA, NPK, TAC2}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, LRP1 (LDL receptor related protein 1) [NCBI Gene 4035] {aka A2MR, APOER, APR, CD91, DDH3, IGFBP-3R}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}, ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363] {aka ABC29, ABCC, DFNA77, GS-X, MRP, MRP1}, FFAR4 (free fatty acid receptor 4) [NCBI Gene 338557] {aka BMIQ10, GPR120, GPR129, GT01, O3FAR1, OB10Q}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, MGLL (monoglyceride lipase) [NCBI Gene 11343] {aka HU-K5, HUK5, MAGL, MGL}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, FAAH (fatty acid amide hydrolase) [NCBI Gene 2166] {aka FAAH-1, FAAH1, PSAB}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CD14 (CD14 molecule) [NCBI Gene 929], CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948] {aka BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV}, ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, ABCA1 (ATP binding cassette subfamily A member 1) [NCBI Gene 19] {aka ABC-1, ABC1, CERP, HDLCQTL13, HDLDT1, HPALP1}, FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867] {aka FFA2R, GPR43}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, DLX5 (distal-less homeobox 5) [NCBI Gene 1749] {aka SHFM1, SHFM1D}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, PTCH1 (patched 1) [NCBI Gene 5727] {aka BCNS, BCNS1, NBCCS, PTC, PTC1, PTCH}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, DISP1 (dispatched RND transporter family member 1) [NCBI Gene 84976] {aka DISPA, HPE10}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, FFAR3 (free fatty acid receptor 3) [NCBI Gene 2865] {aka FFA3R, GPR41}
- **Diseases:** ciliopathies (MESH:D000072661), systemic lupus erythematosus (MESH:D008180), myelodysplastic syndrome (MESH:D009190), neurological disorders (MESH:D009461), metabolic disorders (MESH:D008659), genetic disorders (MESH:D030342), hypercholesterolemia (MESH:D006937), osteonecrosis of the femoral head (MESH:D000070603), obese (MESH:D009765), adiposity (MESH:D018205), hypoxic (MESH:D002534), osteoporosis (MESH:D010024), osteoporotic (MESH:D058866), osteonecrosis (MESH:D010020), cancer (MESH:D009369), fracture (MESH:D050723), demyelination (MESH:D003711), glioma (MESH:D005910), inflammation (MESH:D007249), arthritis (MESH:D001168)
- **Chemicals:** SCFA (MESH:D005232), cannabinoid (MESH:D002186), ROS (MESH:D017382), Cholesterol (MESH:D002784), acetic (MESH:D019342), DHEA (MESH:C000628804), inulin (MESH:D007444), oleic acid (MESH:D019301), propionic acid (MESH:C029658), Endocannabinoids (MESH:D063388), docosahexaenoic acid (MESH:D004281), Palmitic acid (MESH:D019308), free fatty acids (MESH:D005230), stearic acid (MESH:C031183), arachidonic acid (MESH:D016718), lipid (MESH:D008055), omega-6 fatty acids (MESH:D043371), steroid (MESH:D013256), butyric acid (MESH:D020148), eicosapentaenoic acid (MESH:D015118), phospholipids (MESH:D010743), MUFAs (MESH:D005229), TCA (MESH:D014233), hydrocarbon (MESH:D006838), Fatty acids (MESH:D005227), carbohydrates (MESH:D002241), valproic acid (MESH:D014635), triglyceride (MESH:D014280), essential fatty acids (MESH:D005228), catecholamine (MESH:D002395), lactic acid (MESH:D019344), omega-3 fatty acids (MESH:D015525), oxygen (MESH:D010100), PUFAs (MESH:D005231), atorvastatin (MESH:D000069059), N-palmitoylethanolamide (MESH:C005958), cuprizone (MESH:D003471), palmitoleic acid (MESH:C008757), linoleic acid (MESH:D019787), 2-AG (MESH:C094503), phosphatidylethanolamine (MESH:C483858), fat (MESH:D005223), 16:1omega-7 (-), olive oil (MESH:D000069463)
- **Species:** Romboutsia ilealis (species) [taxon 1115758], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], Lactobacillus johnsonii (species) [taxon 33959]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936775/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936775/full.md

## References

151 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936775/full.md

---
Source: https://tomesphere.com/paper/PMC12936775